GX Acquisition (GXGXU) Stock Price, News & Analysis

Company Overview

GX Acquisition was a special purpose acquisition company (SPAC) formed to identify and complete a business combination with an operating company. Rather than selling products or services of its own, the company raised capital through its offering of securities and held those funds while evaluating potential merger, acquisition, or similar transactions.

GX Acquisition completed a business combination with Celularity, a biotechnology company focused on cellular therapies and regenerative medicine. Following the transaction, Celularity became a publicly traded company, and GX Acquisition no longer operated as an independent blank-check company. Information about GX Acquisition’s standalone operations, geographic footprint, and leadership is limited because its principal purpose was to facilitate that transaction.

Key Stats

• Today's Range: $9.00 to $14.00
• 50-Day Range: $11.63 to $11.63
• 52-Week Range: $8.52 to $14.00
• Volume: 16,100 shs
• Average Volume: 6,479 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GXGXU
• CIK: N/A
• Web: celularity.com
• Phone: (212) 616-3700
• Fax: N/A
• Employees: 220
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A